The company entered a new financing agreement for a $200M initial term loan and a $150M delayed draw facility. This fresh capital is earmarked for operating expenses, capital expenditures, lab build-outs, and commercial expansion, indicating significant near-term spending ability.
Filing excerpt
On April 1, 2026, we entered into a new financing agreement (the “2026 Financing Agreement”) with Blue Owl Capital Corporation, as administrative agent, and certain lenders party thereto. The 2026 Financing Agreement provides for an initial term facility of $200.0 million, which was fully drawn on April 1, 2026, and a delayed term loan facility of up to $150.0 million.
What this signalsFilings often name leadership changes, deals and spending plans.
Vendors
sec-10qdebtRefinancingGet every 10-Q signal for Caris Life Sciences and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Caris Life Sciences this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/85b9aa30-982d-486f-b693-be70ceb2c223 returns this record as JSON. POST /v1/companies/enrich returns every signal for carislifesciences.com.
{
"signal_id": "85b9aa30-982d-486f-b693-be70ceb2c223",
"signal_type": "sec-10q",
"signal_subtype": "debtRefinancing",
"detected_at": "2026-05-12T09:24:55.459+00:00",
"company": {
"name": "Caris Life Sciences",
"domain": "carislifesciences.com"
},
"data": {
"detail": "The company entered a new financing agreement for a $200M initial term loan and a $150M delayed draw facility. This fresh capital is earmarked for operating expenses, capital expenditures, lab build-outs, and commercial expansion, indicating significant near-term spending ability.",
"metrics": {
"timeframe": "current_year",
"dollar_context": "Total potential new financing from initial and delayed term loans",
"dollar_millions": 350
},
"summary": "Secured new financing agreement for up to $350M from Blue Owl Capital in April 2026",
"excerpts": "On April 1, 2026, we entered into a new financing agreement (the “2026 Financing Agreement”) with Blue Owl Capital Corporation, as administrative agent, and certain lenders party thereto. The 2026 Financing Agreement provides for an initial term facility of $200.0 million, which was fully drawn on April 1, 2026, and a delayed term loan facility of up to $150.0 million.",
"relevance": 1,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/2019410/000201941026000044/cai-20260331.htm",
"filing_date": "2026-05-08",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/31",
"sales_relevance": "Capital available or pressure",
"signal_category": "financial",
"vendors_mentioned": [
"Blue Owl Capital Corporation"
]
}
}
curl https://signals.autobound.ai/v1/signals/85b9aa30-982d-486f-b693-be70ceb2c223 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"carislifesciences.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.